1-12 of 12
J.C Kluin-Nelemans
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Change in Body-Mass-Index and Persisting Symptoms After Pulmonary Embolism

Anja B.U. Mäkelburg, MD, Elke S. Hoendermis, MD PhD, Nic J.G.M. Veeger, PhD, J.C. Kluin-Nelemans, Karina Meijer, MD PhD
Journal: Blood
Blood (2012) 120 (21): 3389.
https://doi.org/10.1182/blood.V120.21.3389.3389
Published: 2012
Journal Articles

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

Francesco d'Amore, Sirpa Leppä, Maria Gomes da Silva, Thomas Relander, Peter De Nully Brown, Eckhart Weidmann, Grete Fossum Lauritzsen, Antonio Pezzutto, Achiel Van Hoof, Michel van Gelder, Jeanette K Doorduijn, Ka Lung Wu, MD, PhD, J.C. Kluin-Nelemans, P.J. Lugtenburg, Milada Jankovska, Mats Merup, Unn-Merete Fagerli, Jan Walewski, Hans Hagberg, Jose Mario Mariz, Per Boye Hansen, Thomas Nösslinger, Ann Janssens, Lena Brandefors, Hilde Demuynck, Martyn Ronald Schaafsma, Ilse Christiansen, David Salek, Sirkku Jyrkkiö, Vit Prochazka, Josee Zijlstra, L. Böhmer, Richard Greil, MD, Wendy Stevens, Rob Fijnheer, Marinus van Marwijk Kooy, Matthias Grube, Georg Hopfinger, MD, Eric Van den Neste, Esa Jantunen, Lorenz Trümper, Gerald Wulf, Bettina Altmann, Marita Ziepert, Markus Loeffler, Helle Toldbod
Journal: Blood
Blood (2012) 120 (21): 57.
https://doi.org/10.1182/blood.V120.21.57.57
Published: 2012
Journal Articles

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

Francesco d'Amore, MD, DMSci, Maria Gomes da Silva, Sirpa Leppa, Thomas Relander, Antonio Pezzutto, Grete F. Lauritzsen, Eckhart Weidmann, Michel Van Gelder, Mats Merup, Hans Hagberg, Unn-Merete Fagerli, Peter de Nully Brown, Per Boye Hansen, Jose Mario Mariz, Milada Jankovska, Jan Walewski, MD, PhD, Jeanette Doorduijn, Achiel Van Hoof, Ilse Christiansen, Sirkku Jyrkkiö, J.C. Kluin-Nelemans, Marinus van Marwijk Kooy, Rob Fijnheer, Wendy Stevens, Josee Zijlstra, L. Böhmer, P.J. Lugtenburg, Matthias Grube, Vit Prochazka, David Salek, Richard Greil, MD, Lorenz Trümper, Gerald Wulf, Bettina Altmann, Marita Ziepert, Markus Loeffler, Esa Jantunen, Georg Hopfinger, Eric Van den Neste, MD, Helle Toldbod
Journal: Blood
Blood (2011) 118 (21): 4110.
https://doi.org/10.1182/blood.V118.21.4110.4110
Published: 2011
Journal Articles

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

J.C. Kluin-Nelemans, E. Hoster, J. Walewski, MD, S. Stilgenbauer, M.D., C. H. Geisler, C. Gisselbrecht, MD, U. Vehling-Kaiser, MD, J. K. Doorduijn, MD, M. Trneny, MD, B. Coiffier, MD, R. Forstpointner, MD, H. Tilly, MD, L. Kanz, MD, M. Szymczyk, MD, O. Hermine, MD, PhD, W. Klapper, MD, W. Hiddemann, MD, M. Unterhalt, PhD, M. H. Dreyling, MD
Journal: Blood
Blood (2011) 118 (21): 439.
https://doi.org/10.1182/blood.V118.21.439.439
Published: 2011
Journal Articles

Sufficient and Timely Autologous Stem Cell Harvest After Chemoimmunotherapy with Alemtuzumab In Combination with Bi-Weekly CHOP as First Line Treatment In Systemic Peripheral T-Cell Lymphomas (PTCL): a Feasibility Analysis From the First Randomized Trial In Systemic PTCL (ACT trial)

Francesco d'Amore, Maria Gomes da Silva, Sirpa Leppa, Antonio Pezzutto, Thomas Relander, Grete Fossum Lauritzsen, Eckhart Weidmann, Michel Van Gelder, Jeanette Doorduijn, J.C. Kluin-Nelemans, Marinus van Marwijk Kooy, Rob Fijnheer, Okke de Weerdt, Peter de Nully Brown, Per Boye Hansen, Mats Merup, Matthias Grube, Jose Mario Mariz, Jan Walewski, Lorenz Truemper, Gerald Wulf, Esa Jantunen, Georg Hopfinger, it Prochazka, V
Journal: Blood
Blood (2010) 116 (21): 2395.
https://doi.org/10.1182/blood.V116.21.2395.2395
Published: 2010
Journal Articles

Alemtuzumab-CHOP for Aggressive T Cell Lymphoma. A Phase II HOVON 69 Trial.

J.C. Kluin-Nelemans, MD, PhD, Marinus Van Marwijk Kooij, MD, PhD, P.J. Lugtenburg, MD, PhD, Pierre W Wijermans, Willem JL Van Putten, MSc, Gustaaf W van Imhoff, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1999.
https://doi.org/10.1182/blood.V112.11.1999.1999
Published: 2008
Journal Articles

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission in Mantle Cell Lymphoma: Long Term Follow up of a Randomized Trial of the

Martin H. Dreyling, MD, Eva Hoster, PhD, Achiel Van Hoof, Bernd Metzner, Christian Gisselbrecht, Michael Pfreundschuh, MD, PhD, Marcel Reiser, Lorenz H. Truemper, MD, PhD, Hjalmar Steinhauer, Jean-Michel Boiron, MD, PhD, Marc Boogaerts, MD, PhD, Vittorio Silingardi, J.C. Kluin- Nelemans, MD, PhD, Michael Unterhalt, Wolfgang Hiddemann
Journal: Blood
Blood (2008) 112 (11): 769.
https://doi.org/10.1182/blood.V112.11.769.769
Published: 2008
Journal Articles

European MCL Network : An Update on Current First Line Trials.

Martin H. Dreyling, Eva Hoster, Olivier Hermine, J.C. Kluin-Nelemans, Jan Walewski, Marek Trneny, Christian H. Geisler, Michael Unterhalt, Wolfgang Hiddemann
Journal: Blood
Blood (2007) 110 (11): 388.
https://doi.org/10.1182/blood.V110.11.388.388
Published: 2007
Journal Articles

The Effect of Platelet -, and Leukocyte Count on the Thrombelastograph® (TEG) Parameters.

W.W.H. Roeloffzen, J.C. Kluin-Nelemans, Joost de Wolf
Journal: Blood
Blood (2004) 104 (11): 3971.
https://doi.org/10.1182/blood.V104.11.3971.3971
Published: 2004
Journal Articles

In Normal Controls, a Lower Hb Concentration and Female Sexe Increases Coagulability on the Thrombelastograph (TEG).

W.W.F. Roeloffzen, J.C Kluin-Nelemans, Joost de Wolf
Journal: Blood
Blood (2004) 104 (11): 3970.
https://doi.org/10.1182/blood.V104.11.3970.3970
Published: 2004
Journal Articles

Imatinib Mesylate in the Treatment of Systemic Mastocytosis, a Phase I/II Trial.

H.J. Droogendijk, J.C. Kluin-Nelemans, P.L.A van Daele
Journal: Blood
Blood (2004) 104 (11): 1516.
https://doi.org/10.1182/blood.V104.11.1516.1516
Published: 2004
Journal Articles

Activated Cytotoxic T Cells as Prognostic Marker in Hodgkin's Disease

J.J. Oudejans, N.M. Jiwa, J.A. Kummer, G.J. Ossenkoppele, P. van Heerde, J.W. Baars, Ph.M. Kluin, J.C. Kluin-Nelemans, P.J. van Diest, J.M. Middeldorp, C.J.L.M. Meijer
Journal: Blood
Blood (1997) 89 (4): 1376–1382.
https://doi.org/10.1182/blood.V89.4.1376
Published: 1997